Drug Type Universal CAR-T |
Synonyms SMART 201, SMART201 |
Target- |
Mechanism Gene transference, T lymphocyte replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Smart Immune SASStartup |
Active Organization Smart Immune SASStartup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hematologic Neoplasms | Preclinical | FR | Smart Immune SASStartup | 18 Mar 2022 |